TheRyte Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

TheRyte General Information

Description

Provider of cancer therapeutic devices and drugs designed to revolutionize cancer treatments. The company is engaged in creating treatments that target the processes that normally stabilize the cancer cell and developing biomarkers to predict treatment response, enabling patients to recover faster.

Contact Information

Website
www.theryte.com
Formerly Known As
Earthmetal, Bioclin
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • William Russell House
  • The Square, Surrey
  • Lightwater GU18 5SS
  • England, United Kingdom
+44 01276
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • William Russell House
  • The Square, Surrey
  • Lightwater GU18 5SS
  • England, United Kingdom
+44 01276

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TheRyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 16-Jan-2018 Completed Out of Business
4. Grant 14-Nov-2011 Completed Generating Revenue
3. Later Stage VC 15-Sep-2011 Completed Generating Revenue
2. Later Stage VC 10-Sep-2008 $455K $455K Completed Generating Revenue
1. Later Stage VC Completed Generating Revenue
To view TheRyte’s complete valuation and funding history, request access »

TheRyte Patents

  • 78

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • Pending

  • Expiring in next 12 mo

TheRyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0805141-D0 Companion diagnostic for cancer Inactive 19-Mar-2008
GB-0804496-D0 Treating cancer Inactive 11-Mar-2008
EP-2260098-A1 Treating cancer Inactive 11-Mar-2008
GB-0619271-D0 Treating cancer Inactive 29-Sep-2006
AU-2005254770-A1 Treating cancer Inactive 15-Jun-2004 C12N9/1205
To view TheRyte’s complete patent history, request access »

Ready to get started?

Request a free trial

TheRyte FAQs

  • When was TheRyte founded?

    TheRyte was founded in 1998.

  • Where is TheRyte headquartered?

    TheRyte is headquartered in Lightwater, United Kingdom.

  • What industry is TheRyte in?

    TheRyte’s primary industry is Drug Discovery.

  • Is TheRyte a private or public company?

    TheRyte is a Private company.

  • What is TheRyte’s current revenue?

    The current revenue for TheRyte is .

  • How much funding has TheRyte raised over time?

    TheRyte has raised $455K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »